Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3552 studies found for:    adult stem cell transplants | Interventional Studies
Show Display Options
RSS Create an RSS feed from your search for:
adult stem cell transplants | Interventional Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients
Condition: Adult Stem Cell Hematopoetic Transplant
Interventions: Biological: High-Dose Trivalent Inactivated Influenza Vaccine (HD-TIV);   Biological: Standard Dose Trivalent Inactivated Flu Vaccine
2 Recruiting Maraviroc as GVHD Prophylaxis in Transplant Recipients
Conditions: Diagnoses That Require Stem Cell Transplant;   Graft Versus Host Disease (GVHD)
Intervention: Drug: Maraviroc
3 Recruiting Autologous Adipose-Derived Adult Stem Cell Transplantation for Corneal Diseases
Conditions: Hereditary Corneal Dystrophy;   Keratoconus
Interventions: Procedure: Lipoaspiration;   Procedure: Transplantation
4 Recruiting Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.
Condition: Crohn's Disease
Intervention: Other: Hematopoietic stem cell transplantation
5 Completed Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders
Conditions: Allogeneic Stem Cell Transplant;   Leukemia;   Non-Hodgkins;   Lymphoblastic Lymphoma;   Myelodysplastic Syndrome;   Paroxysmal Nocturnal Hemoglobinuria (PNH)
Intervention: Drug: cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant
6 Recruiting Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
Condition: Veno-occlusive Disease
Interventions: Drug: Defibrotide;   Other: Best Supportive Care
7 Recruiting Autologous Stem Cell Transplantation for Crohn's Disease
Condition: Crohn's Disease
Intervention: Biological: autologous CD34-selected peripheral blood stem cells transplant
8 Completed T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC
Condition: Head and Neck Cancer
Intervention: Biological: autologous EBV specific CTLs
9 Completed Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer
Condition: Hematologic Neoplasms
Intervention: Procedure: Stem Cell Transplantation
10 Recruiting Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients
Condition: Hodgkin Lymphoma
Interventions: Drug: Brentuximab Vedotin;   Procedure: Allogeneic Stem Cell Transplantation;   Drug: Reduced Intensity Conditioning
11 Unknown  Stem Cells for Treating Critical Ischemia
Conditions: Critical Limb Ischemia;   Ischemic Ulcers
Intervention: Procedure: stem cells transplant
12 Active, not recruiting Individualized Nutrition for Adult Recipients of Allogeneic Stem Cell Transplants - Effect on Quality of Life
Condition: Effect of Individualized Nutrition on Quality of Life
Intervention: Dietary Supplement: Individualized Nutrition
13 Recruiting CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Conditions: Chronic Myeloid Leukemia (CML);   Acute Myelogenous Leukemia (AML);;   Myelodysplastic Syndrome (MDS);;   Juvenile Myelomonocytic Leukemia (JMML);;   Acute Lymphoblastic Leukemia (ALL);;   Lymphoma (Hodgkin's and Non-Hodgkin's)
Interventions: Device: CliniMACS CD34+ Reagent System;   Drug: Thiotepa;   Drug: Cyclophosphamide;   Drug: Alemtuzumab;   Drug: Tacrolimus;   Drug: Melphalan;   Drug: Busulfan;   Drug: Fludarabine;   Drug: Methylprednisolone
14 Completed MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Condition: Cytomegalovirus Infections
Interventions: Drug: MK-8228;   Drug: Placebo
15 Completed Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload
Condition: Iron Overload
Intervention: Drug: deferasirox
16 Completed Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant
Conditions: Type 1 Diabetes;   Type 2 Diabetes
Intervention: Biological: Autologous CD34+ stem cells
17 Active, not recruiting Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML
Condition: Acute Myeloid Leukemia (AML)
Intervention: Biological: Hematopoietic stem cells from bone marrow or peripheral blood
18 Completed Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia;   Stem Cell Transplantation, Hematopoietic
Interventions: Drug: TBI/CY/VP-16;   Drug: FA-TBI/CY/VP-16
19 Not yet recruiting Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Stem Cell Transplant Patients
Conditions: Blood And Marrow Transplantation;   Adult Respiratory Distress Syndrome
Interventions: Biological: Mesenchymal Stem Cells (MSCs);   Other: Placebo;   Other: Standard of Care Treatment
20 Recruiting CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Conditions: Bone Marrow Failure Syndrome;   Severe Aplastic Anemia;   Severe Congenital Neutropenia;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Schwachman Diamond Syndrome;   Primary Immunodeficiency Syndromes;   Acquired Immunodeficiency Syndromes;   Histiocytic Syndrome;   Familial Hemophagocytic Lymphocytosis;   Lymphohistiocytosis;   Macrophage Activation Syndrome;   Langerhans Cell Histiocytosis (LCH);   Hemoglobinopathies;   Sickle Cell Disease;   Sickle Cell-beta-thalassemia
Intervention: Biological: CD34 Stem Cell Selection Therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.